Cannabinoids may provide a potential therapeutic target for sexual dysfunctions, according to a study published in the journal Pharmacological Research. The study was published online by the U.S. National Institute of Health. “The endocannabinoid system (ECS), which is composed of the cannabinoid receptors types 1 and 2 (CB1 and CB2) for marijuana’s psychoactive ingredient Δ9-tetrahydrocannabinol …
